BFM
RKDA icon

Boothbay Fund Management’s Arcadia Biosciences RKDA Stock Holding History

Boothbay Fund Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,259
Closed -$149K – 2141
2021
Q2 		$149K Sell
1,259
-281
-18% -$30.6K ﹤0.01% 1640
2021
Q1 		$170K Buy
+1,540
New +$189K 0.01% 1394

Other funds holding RKDA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Boothbay Fund Management's RKDA Position: Q3 2021 in Review

Boothbay Fund Management sold out of Arcadia Biosciences (RKDA) in Q3 2021, closing a stake of 1,259 shares — an estimated $149K sold.

Boothbay Fund Management first reported a position in RKDA in Q1 2021 and held it in 2 quarters. The position peaked at $170K in Q1 2021. 21 funds tracked by Wall St. Rank hold RKDA as of Q3 2021.

  • Boothbay Fund Management reported no remaining Arcadia Biosciences position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 1,259 Arcadia Biosciences shares in Q3 2021, an estimated $149K.
  • Boothbay Fund Management first reported a position in Arcadia Biosciences in Q1 2021 and held it in 2 quarters.
  • Boothbay Fund Management's Arcadia Biosciences position peaked at $170K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.